Showing results (751-760 of 3,789) with videos related to
Sort By:
Pageof 379
Oncoimmunology|March 26, 2019
Failure of immunosurveillance accelerates agingMaria Perez-Lanzon, Laurence Zitvogel, Guido KroemerOncoimmunology|January 30, 2014
Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibodyBryan D Choi, Patrick C Gedeon, Luis Sanchez-Perez, et al.Oncoimmunology|May 8, 2014
Obesity and renal cancer: Role of adipokines in the tumor-immune system conflictAsma Gati, Soumaya Kouidhi, Raja Marrakchi, et al.Oncoimmunology|March 1, 2021
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndromeChristoph Iselin, Yun-Tsan Chang, Tanja Schlaepfer, et al.Oncoimmunology|March 1, 2021
Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitorsAntonios Valachis, Camilla Rosén, Anthoula Koliadi, et al.Oncoimmunology|January 10, 2014
The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+ T cells into innate-like effector cells with antitumor activityHing C Wong, Emily K Jeng, Peter R RhodeOncoimmunology|January 10, 2014
The interplay between regulatory T cells and metabolism in immune regulationHu Zeng, Hongbo ChiOncoimmunology|January 4, 2014
hTERT deficiency in naïve T cells affects lymphocyte homeostasis in myelodysplastic syndrome patientsLili Yang, Erika A Eksioglu, Sheng WeiOncoimmunology|May 21, 2014
slanDCs in carcinoma-draining lymph nodesWilliam Vermi, Silvia Lonardi, Mattia Bugatti, et al.Oncoimmunology|August 31, 2012
Can the exome and the immunome converge on the design of efficient cancer vaccines?Guido Kroemer, Laurence ZitvogelPageof 379